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ABSTRACT 
The purpose of this study was to investigate the effects of Commiphora mukul gum resin eth-
anolic extract (CMEEt) administration against altered activities of key enzymes of carbohy-
drate metabolism, lipid metabolism and changes in glycogen content (liver and muscle) and 
lipids (liver and heart) in streptozotocin (STZ) induced insulin deficient diabetic Wistar albino 
rats. Diabetes was induced by intraperitoneal injection of STZ (55 mg/kg body wt) to male 
Wistar rats. The animals were divided into four groups: Control (C), control-treated (C+CM), 
diabetic (D) and diabetic-treated group (D+CM). Diabetic-treated and control-treated rats 
were treated with C. mukul gum resin ethanolic extract (CMEEt) in 2 ml distilled water, orally 
(200 mg/kg body weight/day for 60 days). At the end of the experimental period, biochemical 
parameters related to carbohydrate and lipid metabolism were assayed. The significant en-
hancement in tissue lipids (heart and liver) total cholesterol, triglycerides, phospholipids and 
free fatty acids of diabetic rats were nearer to normalized in diabetic treated rats (D+CM). Al-
terations in the activities of enzymes of glucose metabolism (hexokinase, phosphofructoki-
nase, pyruvate kinase, and glucose-6-phosphatase, fructose-1,6-bisphosphatase and glucose-6-
phosphate dehydrogenase) and lipid metabolism (fatty acid synthase, malic enzyme and lipo-
protein lipase) as observed in diabetic (D) rats were prevented with CMEEt administration. In 
conclusion, our findings indicate improvement of glucose and lipid metabolisms in STZ in-
duced diabetic rats by treatment with Commiphora mukul and suggest that the plant can be 
used as an adjuvant for the prevention and/or management of insulin deficiency and disorder 
related to it. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disor-
der of multiple aetiology characterized by 
chronic hyperglycemia with disturbances of 
carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion, 
insulin action or both (Kaleem et al., 2008). 
Globally, the estimated incidence of diabe-
tes and projection for year 2030, as given 
by International Diabetes Federation (IDF) 
is 350 million (Thounaojam et al., 2010). 
The rapid increase in the incidence of type-
1 diabetes strongly suggests that the action 
of the environment on susceptibility genes 
contributes to the evolving epidemiology of 
type-1 diabetes (Gillespie, 2006). 
Liver is an insulin dependent tissue, 
which plays a pivotal role in glucose and li-
pid homeostasis and is severely affected 
during diabetes mellitus. It has been shown 
to decrease the activities of enzymes in the 
glycolytic and pentose phosphate pathways, 
increased activities of gluconeogenesis and 
glycogenolytic pathways (Mc Anuff et al., 
2005). Medicinal plants play an important 
role in the management of diabetes mellitus 
especially in developing countries where 
resources are meager. Many studies have 
confirmed the benefits of medicinal plants 
with hypoglycemic effects in the manage-
ment of diabetes mellitus. The effects of 
these plants may delay the development of 
diabetic complications and correct the met-
abolic abnormalities. Moreover, during the 
past few years some of the bioactive drugs 
isolated from hypoglycemic plants showed 
antidiabetic activity with more efficacy than 
oral hypoglycemic agents used in clinical 
therapy (Bnouham et al., 2006). Herbal 
remedies are apparently effective with min-
imal or no side effects in chemical experi-
ence and are of relatively low costs as com-
pared to oral synthetic hypoglycemic agents 
(Gupta et al., 2005). 
Commiphora mukul (synonym C. 
whighitti) (family Burseraceae) commonly 
called as gum guggulu is highly valued in 
Ayurveda an Indian system of medicine 
practiced in India, Bangladesh and Paki-
stan. It is a large thorny shrub or a small 
tree, with spiny, ascending branches. The 
gum resin extract of C. mukul tree has been 
used in Ayurvedic medicine for more than 
2000 years to treat a variety of ailments like 
obesity, lipid disorders, rheumatoid arthri-
tis, bone fracture, cardiovascular disorder 
disease (Chander et al., 2003). Traditional 
(India) uses of C. mukul (CM) are for its 
anti-inflammatory, antispasmodic, carmina-
tive, emmenagogue, hypoglycemic, alterna-
tive, antiseptic, and astringent, a thyroid 
stimulant, anthelminitic, antihyperlipidem-
ia, antidiabetic and antioxidant properties 
(Ramesh et al., 2011). It is an important 
herb used in the treatment of several degen-
erative disorders in modern medicine too 
and established as a hypolipidemic drugs 
(Ulbricht et al., 2005). Ayurvedic medi-
cines containing gum guggul often contain 
guggul in their names, such as in Shunthi-
guggul, and Yogaraja guggul. All the for-
mations used for traditional Ayurvedic 
treatments for obesity contained gum gug-
gul among its herbal ingredients. Two ste-
reo isomers, E- and Z-guggulsterone (cis- 
and trans- 4, 17(20)-pregnadiene-3, 16-
dione, respectively), are the most important 
constituents studied in detail for their thera-
peutic potential from C. mukul. Various 
studies have been conducted to understand 
and illustrate the mechanism of action and 
potential of guggulsterone as a therapeutic 
agent using synthetic E and Z isomers (Bur-
ris et al., 2005; Ding and Staudinger, 2005; 
Ichikawa and Aggarwal, 2006). 
Earlier work in our laboratory has 
shown that alcoholic extract of C.mukul 
gum resin has significant antihyperglyce-
mic and antioxidant activities in STZ in-
duced diabetic rats and fructose fed insulin 
resistant Wistar rats (Ramesh et al., 2011, 
Ramesh and Saralakumari, 2012). Guggul-
sterone, the bioactive constituent of guggul, 
has been identified as an antagonist of the 
nuclear farnesoid X receptor (FXR) (Urizar 
et al., 2002) a key transcriptional regulator 
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for the maintenance of cholesterol and bile 
acid homeostasis (Cai and Boyer, 2006). 
Although numerous reports are available on 
the hypolipidemic nature and its plausible 
relation with type II diabetes treatment, in 
place of natural guggulsterone its synthetic 
counterparts have been used in most of the 
cases. The synthetic products mainly con-
sist of either E- or Z-forms instead of the 
combination of them, as they exist naturally 
in guggul lipids along with other compo-
nents as mentioned and recommended in 
traditional Ayurvedic literature. 
 
MATERIAL AND METHODS 
Chemicals 
Acetyl Co-A, malonyl Co-A, pyruvate 
kinase, streptozotocin, lactate dehydrogen-
ase and glucose-6-phosphate dehydrogen-
ase were obtained from the Sigma Chemi-
cals Co. St. Louis, Mo, USA. All other 
chemicals and solvents were of analytical 
grade and procured from Sisco Research 
Laboratories (P) Ltd., Mumbai, India. 
 
Plant material 
Ethanolic extract of Commiphora mukul 
gum resin (CMEE; brown, dry powder with 
Lot No. L5111031) was obtained from the 
manufacturers and exporters of herbal ex-
tracts, Ms Plantex Pvt. Ltd., Vijayawada, 
Andhra Pradesh, India. Procedure followed 
by the firm for the preparation of extract is 
as follows: the plant was identified by Dr. 
K. Narasimha Reddy, Taxonomist, Laila 
impex R & D Center, Vijayawada. The col-
lected plant sample (resin) was washed 
thoroughly with tap water, dried at room 
temperature away from sun light, cut into 
small pieces, and then powdered. Ethanolic 
extract was prepared by cold maceration of 
gum resin powder in ethanol for 7 days. 
The extract was filtered, concentrated under 
reduced pressure and finally dried in a vac-
uum desiccator. Herb-to-product ratio was 
8:1. A voucher specimen has been deposit-
ed in the Department of Biochemistry, Sri 
Krishnadevaraya University, Anantapur, 
under number DSK-CM-09. The extract 
was stored at 0–4 °C and dissolved in water 
just before use. 
 
Animals 
Nine week old male albino Wistar rats 
of body weight 160 – 180 g were procured 
from Sri Raghavendra enterprises (Banga-
lore, India), acclimatized for 7 days to our 
animal house, and maintained at standard 
conditions of temperature and relative hu-
midity, with a 12 h light/dark cycle. Water 
and commercial rat feed were provided ad 
libitum. The current work was carried out 
with a prior permission from our institu-
tional animal ethical committee (Regd. 
No.470/01/a/CPCSEA, dt 24th Aug 2001). 
Diabetes was induced in overnight fasted 
rats by a single intraperitonial injection of 
freshly prepared STZ solution (55 mg/Kg/ 
body weight, in ice cold 0.1M citrate buff-
er, pH 4.5 in a volume of 0.1 ml per rat). 
After 72 h of STZ administration, the plas-
ma glucose level of each rat was deter-
mined for confirmation of diabetes. Rats 
with plasma glucose level above 250 mg/dl 
were considered as diabetic and were used 
in the experiment. 
 
Experimental design  
In the present experiment, a total of 32 
rats (16 diabetic rats; 16 normal rats) were 
used. The rats were divided into four 
groups of 8 each:  
 Control (C);  
 Control rats treated with C. mukul 
(C+CM);  
 diabetic (D); and  
 diabetic rats treated with C. mukul 
(D+CM).  
Diabetic treated group and Control 
treated group received an ethanol extract of 
the Gum resin of C. mukul (2 ml of 5 % 
Tween-80) by orogastric tube at a dose of 
200 mg/kg body weight for 60 days, where-
as, 2 ml of distilled water was administered 
to control and diabetic rats. Based on pre-
liminary experiment on dose–dependent an-
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tihyperglycemic effect of CMEEt, a dose 
less than 200 mg/kg body eight was not ex-
pected to be effective in rats (Ramesh et al., 
2011). At the end of experimental period of 
60 days, animals were sacrificed by cervical 
decapitation. Liver, kidney, heart and vis-
ceral adipose tissues were collected. The 
extraction of lipids from liver and heart 
were carried out according to the procedure 
of Folch et al. (1957). Total cholesterol, tri-
glycerides (Span Diagnostic kit, Surath, In-
dia), free fatty acids (Duncombe, 1963) and 
phospholipids (Connerty et al., 1961) were 
analyzed. Protein content in the tissue ho-
mogenates was estimated by the method of 
Lowry et al. (1951). 
 
Glycogen estimation 
Hepatic and muscle glycogen content 
were determined by using anthrone reagent 
as adapted by (Carroll et al., 1956) 
 
Enzyme assays 
10 % liver homogenate was prepared in 
ice cold 0.1 M Tris-HCl buffer, pH 7.4, 
centrifuged at 12,000 rpm for 45 min in 
Sigma laboratory centrifuge 3K18 model, 
rotor no. 12150. The clear supernatant thus 
obtained with the cytosolic fraction was 
used for the assay of hexokinase (Brand-
strup et al., 1957), phosphofructokinase 
(Sadava et al., 1997), pyruvate kinase (Sa-
dava et al., 1997), glucose-6-phosphatase 
(King, 1965), fructose-1,6-bisphosphatase 
(Sadava et al., 1997), glycogen phosphory-
lase (Sutherland, 1955), glucose-6- phos-
phate dehydrogenase (Beutler, 1975), fruc-
tokinase (Adelman et al., 1966) and malic 
enzyme (Geer et al., 1980). For the fatty ac-
id synthetase, the tissue was homogenized 
at 4 °C in 0.1 M potassium phosphate buff-
er, pH 8.0. The homogenate was centri-
fuged at 30, 000 rpm at 4 °C for 30 min and 
the clear supernatant collected was used for 
the assay of fatty acid synthetase (Gibson 
and Hubbard, 1960). Assay of lipoprotein 
lipase in adipose tissue was done following 
the method of Shirai and Jackson (1982). 
Statistical analysis 
Data were expressed as the mean ± SE 
for the number, n = 8 of animals in the 
group as indicated in (Tables 1–3). The data 
were subjected to statistical analysis by 
Duncan’s Multiple Range (DMR) (Duncan, 
1955) test. Values of p < 0.05 were consid-
ered statistically significant. 
 
RESULTS 
Effect of CMEEt on glycogen content in 
liver and skeletal muscle 
The glycogen content of liver and skele-
tal muscle of experimental group is pre-
sented in Figure 1. The D-Group showed 
significantly decreased glycogen content in 
liver (61.2 %) and muscle (68.3 %) when 
compared to control group. Significant in-
crease in the glycogen content of liver 
(60 %) and muscle (67.24 %) by C. mukul 
administration in DT group was observed 
when compared to the D-group which 
reached normal levels. C. mukul treated 
control rats (C+CM) showed no significant 
variation in the glycogen content of liver 
and muscle when compared to control rats. 
 
Effect of C. mukul on the activities of 
hexokinase, phosphofructokinase,  
pyruvate kinase, fructokinase and  
glucose-6-phosphate dehydrogenase 
Table 1 and Figure 2 and 3 show the 
changes in the activities of HK, PFK, PK, 
FK and glucose-6-phosphate dehydrogen-
ase in liver of control and experimental rats. 
The activities of HK, PFK, PK, PFK and 
glucose-6-phosphate dehydrogenase were 
significantly decreased in STZ induced dia-
betic rats when compared with control rats. 
Oral administration of C. mukul gum resin 
ethanol extract to diabetic rats significantly 
increased the activities of these hepatic en-
zymes. The administration of C. mukul gum 
resin ethanol extract to normal rats (con-
trols) resulted in no significant changes. 
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Figure 1: Change in glycogen content in liver and muscle of CON, CON+CMEE, D and D+CM groups 
during the 60 days experimental period. Values are ± S.E., (In triplicate for n = 8 animals). 
 
 
Figure 2: Change in fructokinase activity in liver of CON, CON+CMEE, D and D+CM groups during 
the 60 days experimental period. Values are ± S.E., (In triplicate for n = 8 animals) 
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Figure 3: Change in glucose-6, phosphate dehydrogenase activity in liver of CON, CON+CMEE, D 
and D+CM groups during the 60 days experimental period. Values are ± S.E., (n = 8 animals) 
 
Table 1: Effect of C. mukul treatment on glycolytic enzyme activities of liver in STZ diabetic rats 
Parameter Tissue C C + CM D D + CM 
Hexokinase  
(µmol G6P formed/ 
min/mg protein) 
Liver 4.31 ± 0.069a 4.44 ± 0.067a 2.57 ± 0.06b 4.43 ± 0.066a 
Phosphofructo kinase 
(µmol F1,6 bis phosphate 
formed/min/mg protein) 
Liver 3.81 ± 0.06a 3.73 ± 0.036a 2.18 ± 0.04b 3.60 ± 0.08a 
Pyruvate kinase  
(µmol NADH oxidized/ 
min/mg protein) 
Liver 2.64 ± 0.07a 2.7 ± 0.05a 1.82 ± 0.05a 2.68 ± 0.05a 
Values are mean ± S.E.M., (In triplicate for n = 8 animals). Values with different superscripts within the row are significantly 
different at P<0.05 (Duncan’s multiple range test) 
 
Effect of C. mukul on the activities of F1, 
6-bisphosphatase, glucose 6-phosphatase 
and glycogen phosphorylase 
Table 2 depicts the activities of fructose 
1,6-bisphosphatase, glucose-6-phosphatase 
and glycogen phosphorylase in control and 
experimental rats. The activities of fructose 
1, 6 bisphosphatase, glucose-6-phosphatase 
and glycogen phosphorylase were signi-
ficantly increased in diabetic rats. Oral 
administration of C. mukul gum resin 
ethanol extract to diabetic rats reversed the 
changes in the activities of these hepatic 
enzymes. The administration of C. mukul 
gum resin ethanol extract to control rats 
produced no significant changes in these 
enzymatic activities when compared with 
control rats. 
 
Effect of C. mukul on tissue lipids in STZ 
diabetic rats 
Group D showed Table 3 significantly 
increased liver and heart total cholesterol, 
triglycerides, free fatty acid and phospho-
lipids when compared with control rats. 
Administration of C. mukul gum resin 
ethanol extract in STZ induced diabetic rats 
significantly restored the liver and heart  
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Table 2: Effect of C. mukul treatment on activity of gluconeogenic enzymes in liver and kidney of STZ 
diabetic rats. 
Parameter Tissue C C + CM D D + CM 
F1, 6BPase 
(nmol of 
F6Pformed/min/mg 
protein)  
Liver 0.41 ± 0.005a 0.44 ± 0.0329a 0.84 ± 0.022b 0.46 ± 0.011a 
Kidney 0.19 ± 0.005a 0.16 ± 0.01a 0.22 ± 0.025b 0.17 ± 0.006a 
G6Pase  
(nmol of 
Piformed/min/mg 
protein)  
Liver 21.83 ± 0.58a 21.93 ± 0.424a 48.75 ± 0.727b 22.23 ± 0.25a 
Kidney 18.16 ± 0.86a 18.9 ± 0.56a 23.82 ± 0.54b 18.56 ± 0.46a 
Glycogen  
phosphorylase  
(µmol of Pi formed 
/min/ mg protein) 
Liver 0.13 ± 0.0045a 0.14 ± 0.0036a 0.29 ± 0.0083b 0.15 ± 0.011c 
Values are mean ± S.E.M., (In triplicate for n=8 animals). Values with different superscripts within the row are significantly 
different at P<0.05 (Duncan’s multiple range test). 
 
Table 3: Effect of C. mukul treatment on hepatic and cardiac tissue lipids in control and experimental 
rats 
Parameter Tissue C C + CM D D + CM 
TC 
mg/100g tissue 
Liver 150.88 ± 2.04a 136.53 ± 3.05b 173.54 ± 1.54c 148.75 ± 1.76a 
Heart 64.67 ± 0.89a 58.03 ± 0.52b 76.31 ± 0.69c 66.30 ± 0.84a 
TG  
mg/100 g tissue 
Liver 147.66 ± 1.74a 132.20 ± 1.31b 155.76 ± 3.12c 130.75 ± 1.42a 
Heart 70.88 ± 0.67a 62.58 ± 0.62b 78.86 ± 1.25c 69.78 ± 2.09a 
PLP 
µg/100 g tissue 
Liver 944.3 ± 61.0a 791.83 ± 38.4a 1157.6 ± 61.0b 944.3 ± 61.0a 
Heart 523.0 ± 61.0a 436.8 ± 51.0a 685.5 ± 20.34b 426.3 ± 51.0a 
FFA 
mg/100 g tissue 
Liver 210.20 ± 3.64a 201.65 ± 3.05a 249.86 ± 10.91b 209.03 ± 2.48a 
Heart 131.86 ± 2.39a 124.85 ± 1.00a 163.9 ± 3.12b 127.50 ± 0.64a 
Values are mean ± S.E.M. (in triplicate for n = 8 animals). Values with different superscripts within the row are significantly 
different at P<0.05 (Duncan’s multiple range test). 
 
 
total cholesterol, triglycerides, free fatty 
acids, and phospholipids almost equal to 
control rats. 
 
DISCUSSION 
The main objective of the present study 
is to determine whether Commiphora 
mukul gum resin, implicated as a hypo-
glycemic agent, modulates key enzymes 
involved in glucose metabolism in two pe-
ripheral tissues during its course of action. 
We report here that C. mukul gum resin 
treated to STZ-induced diabetic rats modu-
late key glucose metabolizing enzymes in 
both liver and kidney, resulting in normal 
blood glucose homeostasis. STZ-injection 
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activation of G6PDH and decreased glucose 
production by depression of key gluconeo-
gluconeogenic and glycogenolytic 
enzymes. In the present study the 
significantly decreased activities of these 
glycolytic enzymes observed in the liver 
and skeletal muscle of STZ diabetic rats 
indicated decreased operation of glycolysis 
under diabetic condition in the insulin 
dependent tissue (skeletal muscle) and 
insulin independent tissue (liver). 
Decreased HK activity also indicates 
decreased availability of glucose-6-phos-
phate for HMP shunt operation under 
diabetic condition. A similar trend of 
decreased glycolytic enzyme activities was 
reported in various tissues of diabetic 
animals (Rathi et al., 2002). 
Lowered hepatic G6PDH activity was 
observed in STZ-diabetic rats. Our results 
are in accordance with the earlier reports 
(Bugdayci et al., 2006, Karuna et al., 2010). 
This decrease may be considered as an 
adaptive phenomenon by which the supply 
of NADPH for aldose reductase is cut 
down. Reduced activity of this enzyme in 
diabetic state shows that glucose does not 
enter into pentose phosphate pathway to a 
greater extent. G6PDH activity and 
NADPH/NADP ratio vary inversely in 
relation to blood glucose concentration. 
Studies of Díaz-Flores et al. (2006) 
indicated that decrease in hepatic G6PDH 
activity is dependent on the severity of 
hyperglycemia. The decreased activity of 
G6PDH also indicates that the HMP shunt 
activity is unable to meet the requirement of 
cellular NADPH for the enzymes that 
continuously maintain Hb and GSH in their 
reduced states. The decreased activity of 
this enzyme further indicates the 
accumulation of glucose-6-phosphate which 
is a potent glycosylating agent that causes 
GSH depletion and thereby boosts glycation 
(Jain, 1998) and it may also promote the 
final step of gluconeogenesis (G6Pase). C. 
mukul administration induced moderate 
reversal of this effect in D + CM- rats. 
Insulin is reported to stimulate oxidation of 
glucose by increasing the activation of 
G6PDH in dose dependent manner (Wagle 
et al., 1998).  
In our study, administration of C. mukul 
significantly increased the activity of 
G6PDH in diabetic state. It provides 
hydrogen, which binds to NADP+ and 
produces NADPH and enhances the 
synthesis of fats from carbohydrates, i.e, 
lipogenesis (Abdel-Rahim et al., 1992), 
finally the plasma glucose levels were 
decreased. Previous studies show that 
Umbelliferone, a phenolic compound 
produces the same effect in STZ-diabetic 
rats (Ramesh and Pugalendi, 2006). High 
level of total cholesterol is one of the major 
factors for coronary heart diseases and it is 
well known that hyperlipidemia and the 
incidence of atherosclerosis is increased in 
diabetes (Tan et al., 2005). The liver and 
some other tissues participate in the uptake, 
oxidation and metabolic conversion of free 
fatty acids, synthesis of cholesterol and 
phospholipids and secretion of specific 
classes of plasma lipoprotein. 
Liver plays an important role in 
buffering the postprandial hyperglycemia 
and is involved in synthesis of glycogen. 
Diabetes mellitus is known to impair the 
normal capacity of the liver to synthesize 
glycogen (Sirag, 2009). Synthase 
phosphatase activates glycogen synthase, 
resulting in glycogenesis, and this 
activation appears to be defective in STZ-
induced diabetic rats (Kirana and Srinivas, 
2008). Diabetic rats treated with CMEEt 
had liver glycogen brought back to near 
normal levels, which could be due to 
increased secretion of insulin, which 
enhances glycogenesis. 
Hepatic lipid accumulation may be a 
result of one or several of the following 
factors: increased delivery of dietary fatty 
acids or fatty acids from adipose tissue to 
the liver, increased de nova synthesis of 
fatty acids in the liver, decreased rate of 
hepatic fatty acid oxidation, or decreased 
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rate in the exit of fatty acid from the liver in 
the form of TG. Delivery of fatty acids to 
the liver appears to be the most potent 
mechanism for hepatic lipid accumulation 
(Donnelly et al., 2005). The lipid lowering 
activity of the resin of C.mukul has been 
well documented in various hyperlipaemic 
experiment animals (Sharma et al., 2009) 
and guggulsterone was used as positive 
control to assesses the hyperlipaemic 
activity of other chemical compound 
(Kumari and Augusti, 2007). Several 
studies have shown that guggulsterone 
lowers cholesterol levels by lowering the 
LDL cholesterol but increasing the HDL 
cholesterol. Fatty acid synthase plays a 
central role in de novo lipogenesis in 
animals by catalyzing all the reactions in 
conversation of acetyl COA and malonyl 
CoA to palmitate. Malic enzymes play a 
key role in generation of NADPH for 
lipogenesis. The activates of hepatic malic 
enzyme correlate closely with the rate of 
lipid biosynthesis (Revilla et al., 1987). 
Lipoprotein lipase is an enzyme responsible 
for the hydrolysis of triglycerides from 
plasma lipoproteins and its activity is 
influenced by nutritional and hormonal 
status and by environmental conditions 
(Merkel et al., 2002). Adipose tissue LPL is 
the enzyme that allows the entry of 
lipoprotein packaged fatty acids into 
adipose tissue for storage (Appel et al., 
1992). Excess of fatty acids in serum 
produced by the streptozotocin-induced 
diabetes promotes conversion of excess 
fatty acids into phospholipids and 
cholesterol in liver. These two substances 
along with excess triglycerides formed at 
the same time in liver may be discharged 
into blood in the form of lipoproteins. The 
abnormal high concentration of serum 
lipids in the diabetic subject is mainly due 
to increase in the mobilisation of free fatty 
acids from the peripheral fat depots, since 
insulin inhibits the hormone sensitive 
lipase. Hypercholesterolemia and 
hypertriglyceridemia have been reported to 
occur in streptozotocin diabetic rats 
(Pushparaj et al., 2000; Sharma et al., 1996) 
and significant increase observed in our 
experiment was in accordance to these 
studies. The marked hyperlipidaemia that 
characterize the diabetic state may 
therefore, be regarded as a consequence of 
the uninhibited actions of lipolytic 
hormones on the fat depots (Goodman and 
Gilman, 1985) 
The present studies show that the C. 
mukul gum resin ethanol extract possesses 
definite hypotriglyceridemic and 
antiatherogenic properties in STZ diabetic 
rats after 60 days of treatment. The repeated 
administration of C. mukul extract for a 
period of 60 days resulted in a significant 
decrease in lipid parameters of various 
tissues when compared to the diabetic 
control. Many studies have shown that the 
increase in fatty acid delivery to the liver 
leads to increased triglyceride synthesis 
accompanied by increases in VLDL 
secretion (Sharma et al., 2009). 
 
CONCLUSION 
From the above findings, we conclude 
that C. mukul administration significantly 
increased insulin secretion and normalized 
the deranged carbohydrate metabolism and 
lipid metabolism in diabetic rats by 
enhancing glucose utilization and 
decreasing hepatic glucose production, 
thereby exhibiting significant antidiabetic 
effects. Further studies are needed to 
explore the molecular mechanisms in 
altering hormone secretion. 
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